Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology andp53 status-Reference-Cited by-同舟云学术

Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology andp53 status

Published:1995-11-03 Issue:3 Volume:63 Page:330-336
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Andersson Michael,Wallin Håkan,Jönsson Marzieh,Nielsen Lise L.,Visfeldt Jakob,Vyberg Mogens,Bennett William P.,De Benedetti Virna M. G.,Travis Lois B.,Storm Hans H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. Mortality and Cancer Incidence after Cerebral Arteriography with or without Thorotrast

2. , , , and , Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles. Cancer Epidemiol. Biomarkers Prev., (1995b). (In press).

3. Pleural Malignant Mesothelioma Following Wilms’ Tumor

4. Occurrence of malignant peritoneal mesothelioma after surgery and irradiation for cervical cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and shapes of causal exposure-response functions for asbestos in mesotheliomas and lung cancers;Environmental Research;2023-08

2. Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma;Cancers;2021-08-20

3. Mesothelioma mortality within two radiation monitored occupational cohorts;International Journal of Radiation Biology;2019-07-22

4. A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer;Scientific Reports;2019-05-20

5. Malignant and Borderline Mesothelial Tumors of the Pleura;Practical Pulmonary Pathology: A Diagnostic Approach;2018